Abstract:Pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are ligand-activated transcription factors that regulate the expression of drug metabolizing enzymes and drug transporters. Since their discoveries, they have been studied as important factors for regulating processes related to drug efficacy, drug toxicity, and drug-drug interactions. However, their vast ligand-binding profiles extend into additional spaces, such as endogenously produced chemicals, microbiome metabolites, dietary compounds, and environmental pollutants. Therefore, PXR and CAR can respond to an enormous abundance of stimuli, resulting in significant shifts in metabolic programs and physiologic homeostasis. Naturally, PXR and CAR have been implicated in various diseases related to homeostatic perturbations, such as inflammatory bowel disorders, diabetes, and certain cancers. Recent findings have injected the field with new signaling mechanisms and tools to dissect the complex PXR and CAR biology and have strengthened the potential for future PXR and CAR modulators in the clinic. Here, we describe the historical and ongoing importance of PXR and CAR in drug metabolism pathways and how this history has evolved into new mechanisms that regulate and are regulated by these xenobiotic receptors, with a specific focus on small molecule ligands. To effectively convey the impact of newly emerging research, we have arranged five diverse and representative key recent advances, four specific challenges, and four perspectives on future directions. SIGNIFICANCE STATEMENT PXR and CAR are key transcription factors that regulate homeostatic detoxification of the liver and intestines. Diverse chemicals bind to these nuclear receptors, triggering their transcriptional tuning of the cellular metabolic response. This minireview revisits the importance of PXR and CAR in pharmaceutical drug responses and highlights recent results with implications beyond drug metabolism.

First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy

Addition/Correction to "First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy"

Targeting Pregnane X Receptor with a Potent Agonist-Based PROTAC to Delay Colon Cancer Relapse

Regulation of PXR in drug metabolism: chemical and structural perspectives

Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis

Regulation of drug resistance by human pregnane X receptor in breast cancer.

Dietary phytochemicals as modulators of human pregnane X receptor

Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development

Novel antagonists reveal the mechanism of PXR inhibition

A Concise Review on Hpxr Ligand-Recognizing Residues and Structure-Based Strategies to Alleviate Hpxr Transactivation Risk.

Regulation of Nuclear Receptors PXR and CAR by Small Molecules and Signal Crosstalk: Roles in Drug Metabolism and Beyond

First small-molecule PROTACs for G protein-coupled receptors: inducing 1A-adrenergic receptor degradation

Ensemble Docking Approach to Mitigate Pregnane X Receptor-Mediated CYP3A4 Induction Risk

Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique.

Mechanistic insights into the synergistic activation of the RXR–PXR heterodimer by endocrine disruptor mixtures

Abstract 6047: Discovery and characterization of PVTX-321, an estrogen receptor heterobifunctional degrader

Pregnane X Receptor Regulates the AhR/Cyp1A1 Pathway and Protects Liver Cells from Benzo-[Α]-pyrene-induced DNA Damage.

Advances in drug resistance of osteosarcoma caused by pregnane X receptor

Treatment of Cardiovascular Disease by Traditional Chinese Medicine Against Pregnane X Receptor

Pregnane X Receptor-Mediated Transcriptional Activation of Udp-Glucuronosyltransferase 1a1 by Natural Constituents from Foods and Herbs

Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimics